INSTITUT CURIE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 34
- Registration Number
- NCT01373710
- Locations
- 🇫🇷
Institut du Cancer de Montpellier, Montpellier, France
🇫🇷Institut Curie - Claudius Regaud Hospital, Paris, Ile De France, France
🇫🇷Oscar Lambret Center, Lille, Nord, France
Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 52
- Registration Number
- NCT01351870
- Locations
- 🇫🇷
Institut Curie, Paris, France
Study of Circulating Tumoral DNA in Ovarian Cancer
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 25
- Registration Number
- NCT01350908
- Locations
- 🇫🇷
Institut Curie, Paris, France
Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-09
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 265
- Registration Number
- NCT01349842
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷Clinique Victor Hugo, Le Mans, France
🇫🇷Chu Limoges, Limoges, France
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 40
- Registration Number
- NCT01334008
- Locations
- 🇫🇷
Institut Curie, Paris, France
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Phase 2
- Conditions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 35
- Registration Number
- NCT01217398
- Locations
- 🇫🇷
Institut Curie Hopital, Paris, France
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
Completed
- Conditions
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 350
- Registration Number
- NCT01210209
- Locations
- 🇫🇷
Institut Curie Hopital, Paris, France
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 76
- Registration Number
- NCT00957411
- Locations
- 🇫🇷
Institut Curie Hopital, Paris, France
Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma
Completed
- Conditions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 15
- Registration Number
- NCT00897624
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
Completed
- Conditions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 216
- Registration Number
- NCT00898014
- Locations
- 🇫🇷
Institut Curie Hopital, Paris, France
© Copyright 2024. All Rights Reserved by MedPath